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ABSTRACT: Developing rapid, efficient, highly sensitive, simple,
stable, and low-cost virus marker detection products that are
appropriate for basic facilities is of great importance in the early
diagnosis and treatment of viruses. Naked-eye detection methods
are especially important when medical testing facilities are limited.
Polystyrene nanospheres (PSs) with catalytic and specific
recognition functions were successfully developed by simulta-
neously modifying catalase and goat anti-hepatitis B surface
antibodies on nanospheres. The modified PSs contributed
significantly to the amplification of the signal. Via the specific
antigen−antibody reaction, the bifunctional nanospheres could be
captured on microplate and then catalyzed the decomposition of
hydrogen peroxide to reduce chloroauric acid and synthesize gold nanoparticles (AuNPs). Due to the surface plasmon resonance of
AuNPs, the solution color change could be observed with the naked eye and the limit of detection (LOD) was 0.1 ng/mL.
Furthermore, the LOD observed with instrumentation was 0.01 ng/mL, which meant that a rapid, efficient, and highly sensitive
method for the detection of hepatitis B surface antigens was successfully developed, and neither complex sample pretreatment nor
expensive equipment was needed.
1. INTRODUCTION
Viral hepatitis is one of the most serious public health
problems. For example, infection with hepatitis B virus (HBV)
will lead to hepatitis B, which is endemic, widespread, and
severely harmful. It can manifest in a variety of clinical types,
such as chronic hepatitis, hepatocellular carcinoma, acute
hepatitis, and cirrhosis,1,2 leading to tens of thousands of
deaths each year. At present, there is no effective treatment
method for HBV at home or abroad, and patients can only be
treated with nucleoside analogues or interferons to inhibit virus
replication and worsening of the liver disease; nevertheless, for
most patients, HBV cannot be eliminated. Therefore, early
diagnosis of HBV is essential for the effective prevention and
treatment of the disease.
The existing methods for detecting HBV include enzyme-
linked immunosorbent assay (ELISA),3 radioimmunoassay
(RIA),4 chemiluminescence immunoassay (CIA),5 and electro-
chemical immunoassay (EIA).6 Using commercially available
ELISA to detect viruses is common because of the specific
reaction of the antigen and the antibody and enzyme catalysis,
but the shortcomings are also apparent; these include low
sensitivity and easily missed inspections for low-level people.
The RIA method is reliable and accurate, but its use suffers
from problems related to health, waste disposal, and the need
for expensive equipment. CIA cannot target a single compound
but will react to a series of compounds, so its selectivity is poor.
Additionally, the selectivity of EIA is usually poor. Therefore,
the development of simple, sensitive, and rapid early clinical
diagnosis and detection methods for HBV is essential for
human health care.7
With the rise and development of nanotechnology, the
unique physicochemical properties of nanomaterials have aided
in the development of new methods for the sensitive detection
of biological analytes, and various nanoparticles, including
quantum dots,8 nano-porphyrins,9 and metal nanoparticles,10
have been used in bioanalytical determinations. Colorimetric
analysis methods based on the surface plasmon resonance
(SPR) of gold nanoparticles (AuNPs), which do not require
advanced instrumentation, have successfully attracted atten-
tion. Because AuNPs offer the advantages of good biocompat-
ibility, unique optical and electronic properties, and relatively
easy manufacturing, they are frequently used as carriers in
various biomedical applications.11 A range of biomacromole-
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cules, such as antibodies, oligonucleotides, and aptamers,12 can
functionalize AuNPs. Biomolecular interactions in biological
processes can control their dispersion and aggregation. By
monitoring the apparent color change caused by AuNPs, the
detection of many kinds of (biological) molecules becomes
easy,12−19 and this provides an excellent platform for the
colorimetric biosensor development. For example, Xiong et al.
detected the Enterovirus 71 by the SPR of AuNPs with a limit
of detection (LOD) equal to 0.65 ng/mL, which is much lower
than the commercial ELISA detection (4.51 ng/mL).20
In this work, we advance a colorimetric detection scheme
based on a specific antibody−antigen interaction, catalase-
mediated growth, and aggregation of AuNPs. The method can
detect hepatitis B surface antigen (HBsAg) directly and in a
simple manner. As shown in Scheme 1, the capture antibody
(mouse anti-HBsAg, MAbs) immobilized on a microplate
specifically recognized and effectively captured HBsAg and
then the HBsAg also combined with polystyrene nanospheres
(PSs) that were modified with goat anti-HBsAg (GAbs) and
catalase (CAT). The whole system formed an immune
sandwich structure complex. More importantly, it also
amplified the detection signal. Then, hydrogen peroxide
(H2O2) decomposition was catalyzed by CAT on the complex
and the remaining H2O2 reduced the Au
3+ and further affected
the morphology of the synthetic AuNPs, which resulted in a
significant transformation of the solution color (from red to
purple and further to blue). The corresponding absorbance
change was proportional to the concentration of HBsAg.
Therefore, the method achieves a highly sensitive, fast,
efficient, and highly specific visual detection of HBsAg.
Moreover, it does not require complex sample preparation,
precision instruments, or specialized technical personnel; thus,
it has broad prospects in clinical diagnosis, especially in
resource-needy areas.
2. RESULTS AND DISCUSSION
2.1. Determination of the Feasibility of the Plan.
Scheme 1 shows the entire process for the visual detection of
HBsAg. Only HBsAg was present, and the GAbs on the
bifunctional nanospheres could bind to the captured HBsAg
on the microplate. Subsequently, the CAT modified on the
bifunctional nanospheres catalyzed the decomposition of
H2O2; this, in turn, affected the morphology of the AuNPs
synthesized with chloroauric acid, leading to the visually
recognized change in the color of the solution. The higher the
Scheme 1. Schematic Diagram of Naked-Eye Detection of
HBsAg Using AuNPs Aggregation and Catalase-
Functionalized PSs
Figure 1. Relationship between the concentration of H2O2 and the morphology of AuNPs was built. A series of different concentrations of H2O2
were reacted with 0.34 mM chloroauric acid solution. (a) Color of the solution containing synthesized AuNPs after 30 min of reaction with
different concentrations of H2O2. (b) UV−vis absorption characteristics of the abovementioned different AuNP solutions. When the H2O2
concentration was less than 0.28 mM, the AuNP local SPR peak red-shifted. (c) Absorbance of different AuNPs at 540 nm varied with the
concentration of H2O2. (d,e) TEM images of AuNPs synthesized when the H2O2 concentrations were (d) 0.24 and (e) 0.32 mM.
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HBsAg concentration was, the greater the color change.
Finally, fast, efficient, highly sensitive, and highly specific visual
detection of HBsAg was achieved. To ensure the feasibility of
the experimental design, it was crucial to prove that the H2O2
concentration could adjust the morphology and optical
properties of the AuNPs synthesized with chloroauric acid.
When a series of different concentrations of H2O2 were
reacted with 0.34 mM chloroauric acid solution, we observed a
conspicuous transformation of the solution color from blue to
purple to red (Figure 1a), which meant that the concentration
of H2O2 did regulate the morphology of the synthesized
AuNPs. This is because, when H2O2 reduces chloroauric acid,
small AuNP seeds are first generated, and then, the generated
seeds continue to grow. If the concentration of H2O2 is low,
the nucleation rate for AuNPs will be slower than the growth
rate, so it is easy to generate AuNPs with large particle sizes. If
the concentration of H2O2 is high, the nucleation rate of
AuNPs will be faster than the growth rate, and it is easy to
generate many scattered AuNPs with small particle sizes. As
shown in Figure 1b,c, when the concentration of H2O2 was less
than 0.28 mM, the local SPR spectrum of the AuNPs
broadened and redshifted to longer wavelengths. Additionally,
transmission electron microscopy (TEM) imaging also
confirmed that the final morphology of the synthesized
AuNPs was strictly dependent on the concentration of H2O2
(Figures 1d,e and S1). In short, more viral antigens meant
more enzymes were connected, less H2O2 remained after
catalytic decomposition, the synthesized AuNPs were more
agglomerated, and the solution color was blue, that is, the
experimental scheme was feasible.
2.2. Optimization of Bifunctional Nanospheres. Based
on the fact that the final morphology of synthesized AuNPs
strictly depended on the concentration of H2O2, we designed
an enzyme-catalyzed reaction in which CAT was used to
decompose H2O2 and affect the morphology of the synthesized
AuNPs. Additionally, to achieve rapid detection, we used PSs
(approximately 300 nm in size) made in the laboratory as the
carrier (Figure 2a,b). If GAbs, CAT, and PSs are reacted
together, competition will occur between GAbs and CAT;
GAbs is more competitive than CAT, which will affect the
modification process. Therefore, we adopted a layer-by-layer
modification method. Considering the issue of competitive-
ness, we first used CAT to occupy all the modification sites on
the PSs and then used poly(ethylene glycol) (PEG) as the
connecting arm between CAT and GAbs to increase the
distance between them; this would reduce the steric hindrance
and enhance the modification effect so that dual-function
nanospheres (PSs@CAT@PEG@GAbs) with strong catalytic
and specific recognition functions could be obtained. When an
antibody molecule on the bifunctional PSs binds to an antigen
molecule, all CAT on the complex will participate in the H2O2
catalytic reaction; therefore, the detection signal would be
amplified and the sensitivity could also be improved. As shown
in Figure 2c,d, in the presence of HBsAg, the addition of dual-
functional nanospheres significantly affected the color of the
final solution, which meant that the dual-functional nano-
spheres achieved the goal of detecting HBsAg. To ensure high
detection sensitivity, the dual-function nanospheres needed to
be optimized.
With 1 mg of PSs, the addition of different amounts of CAT
for coupling resulted in different enzyme activities for the
PSs@CAT obtained. As shown in Figure S2a, when 0.7 mg of
CAT was used, the absorbance was the lowest of those
observed, indicating that the color of the solution was the
lightest and the concentration of H2O2 remaining after
catalysis was the lowest, that is, the highest level of CAT was
modified on the PSs and the best enzyme activity for PSs@
CAT was observed. Similarly, as shown in Figure S2b,c, when 1
mg of PSs, 0.7 mg of CAT, 0.8 mg of PEG, and 30 μg of GAbs
were fixed, the bifunctional nanospheres in the microplate
could catalyze the most H2O2 and the concentration of H2O2
remaining was the lowest, so the solution exhibited the lightest
color and the lowest absorbance. This meant that the coupling
process of the dual-functional PSs had reached the optimal
level, and subsequent testing could be carried out.
2.3. Detection of HBsAg. After obtaining the optimal
dual-functional nanospheres, we sought to optimize each step
of the detection to further improve the detection sensitivity.
The specific optimization conditions are shown in Figure S3.
Because the absorbances of the solutions in the experimental
group at 540 nm were lower than that in the control group, it
was easy to use these differences (ΔA540) to distinguish
successful and unsuccessful experiments. The larger ΔA540 was,
the greater the color difference of the solution, the lighter the
color of the solution in the experimental group with HBsAg
added, which meant the detection sensitivity of HBsAg was
higher under this experimental conditions. That is, the larger
ΔA540 signified better conditions. The remaining detection
conditions were optimized as follows: the concentration of the
capture antibody (MAbs) coated on the microplate was 2 μg/
mL, the reaction time for the specific binding of HBsAg and
the MAbs was 75 min, the reaction time for the HBsAg that
had been captured on the microplate specifically bound to the
GAbs on the bifunctional nanosphere was 45 min, the reaction
time to catalyze the decomposition of H2O2 by CAT on the
dual-functional nanospheres binding to the microplate was 30
min, and, after decomposition, the reaction time for the
remaining H2O2 reducing Au
3+ to produce AuNPs was 10 min.
Figure 2. Characterization of PSs and verification of the feasibility of dual-functional PSs. (a) Corresponding size distribution of PSs. (b) TEM
images of the PSs. In the presence of HBsAg, (c) when bifunctional nanospheres were not added, the color of the final solution was red, and (d)
when bifunctional nanospheres were added, the color of the final solution was blue.
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Under these optimal conditions, different concentrations of
HBsAg were tested. As shown in Figure 3a, when the HBsAg
level increased, the number of combined bifunctional PSs
increased, and the amount of H2O2 decomposed also
increased, which greatly affected the morphology of the
synthesized AuNPs. Additionally, the hue of the solution also
transformed from red into purple, then into blue, and finally
became colorless. To accurately measure the concentration of
HBsAg, the decrease in the absorbance of the experimental
group solution measured at 540 nm relative to that of the blank
control (ΔA540) is plotted in Figure 3b. As shown in Figure 3b,
when the concentration of HBsAg increases, ΔA540 also
increases, indicating that a linear relationship exists in the
range 0.01 and 10 ng/mL, and the linear correlation coefficient
(R2) is 0.989 (inset of Figure 3b). The naked-eye LOD was 0.1
ng/mL and the instrumental LOD was 0.01 ng/mL, indicating
that the immunocolorimetric assay in this paper could detect
HBsAg with high sensitivity.
Furthermore, we compared the method proposed in this
article with other traditional methods, such as ELISA,
polymerase chain reaction (PCR), EIA, and so forth. As
shown in Table 1, comprehensive sensitivity and instrument
requirements indicated the superiority of the proposed method
in naked-eye detection, which is suitable for resource-poor
areas.
2.4. Specificity Verification. To evaluate the specificity of
the method for the detection of HBsAg, other common
markers, such as HBcAg, HBeAg, CEA, and AFP antigen, were
used as negative samples, and 2 mg/mL PBS−BSA solution
was used as a control. As shown in Figure 3c, the blue solution
color caused by the aggregation of AuNPs could barely be
observed in the presence of HBsAg. On the contrary, in the
experiments with negative samples, because the markers could
not combine with immune complexes, they were easily washed
away when the microplate was washed, so the H2O2 added
subsequently would not be catalyzed, and red scattered AuNPs
were ultimately observed. Thus, we know that the color
transformation of the solution was the result of the biospecific
interaction between HBsAg and the corresponding specific
antibody, indicating that our method has high specificity.
Additionally, a microplate reader was used to verify the naked
eye test results. Based on the decrease in absorbance at 540 nm
(ΔA540), the negative and positive samples could be easily
distinguished. These results indicate that this method has high
selectivity for the identification of HBsAg.
2.5. Detection of HBsAg in Spiked Serum Samples.
To further evaluate the applicability of the immunoassay for
detecting HBsAg in the human serum, different concentrations
of HBsAg were added to the serum, which was diluted 40
times, and then, the detection was carried out under the
optimal conditions. As shown in Table 2, recoveries of HBsAg
at different concentrations (0.5−10 ng/mL) in the serum
samples are between 93.44 and 104.67%, the average recovery
is 100.66%, and the relative standard deviation (RSD) is
between 0.04 and 3.61%, indicating that the colorimetric
immunoassay is suitable for detecting HBsAg in serum samples
and have great prospects for the application in actual clinical
practice.
Figure 3. Proposed colorimetric method was used to detect HBsAg. With increasing HBsAg concentration, (a) change in the solution color and
(b) change in absorbance at 540 nm (ΔA540), inset: at low HBsAg concentrations, the concentration was linearly related to absorbance. Other
common markers, such as hepatitis B core antigen (HBcAg), hepatitis B e antigen (HBeAg), carcinoembryonic antigen (CEA), and α-fetoprotein
(AFP) antigen, were used as negative samples, and 2 mg/mL PBS−BSA solution was used as a control to verify the specificity of the method. (c)
Color of the solution and the absorbance of the solution at 540 nm after addition of the samples.
Table 1. Comparison of Different Detection Methods
method detection object LOD references
ELISA HBsAg 0.5 IU/mL 21
CIA HBsAg 14 pg/mL 22
lateral flow HBsAg 75 pg/mL 23
PCR HBV DNA 2000 IU/mL 24
EIA HBsAg 0.343 pg/mL 17
Table 2. Detecting HBsAg in Spiked Serum Samples by the
Proposed Immunoassay
sample spiked (ng/mL) detected (ng/mL) recovery (%) RSD (%)
1 0.5 0.467 93.44 0.04
2 1 1.0467 104.67 0.57
3 4 4.161 104.04 3.61
4 8 7.863 98.29 2.95
5 10 10.284 102.84 2.98
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3. CONCLUSIONS
In conclusion, the immunoassay method involving the CAT-
mediated reduction of chloroauric acid to synthesize AuNPs
has been successfully used to rapidly and visually detect
HBsAg. It provides a simple way of reading results with the
naked eye, using the amplification effect of the PSs and the
enzyme-catalyzed reaction; this allows the detection of HBsAg
with high efficiency, high sensitivity (instrumental LOD = 0.01
ng/mL), and high specificity, allowing the use of the method in
resource-poor rural units. At the same time, the recovery levels
in serum samples with our proposed method are between
93.44 and 104.67% and the RSD is between 0.04 and 3.61%,
further indicating that the novel method has the great
advantages of high specificity and low interference. The visual
detection of HBsAg using immune amplification to catalyze the
synthesis of AuNPs offers great potential for sensitive, reliable,
convenient, and low-cost medical and point-of-care diagnosis.
4. MATERIALS AND METHODS
4.1. Materials. Microplates were purchased from JET. The
ultrafiltration tube (50 k) was purchased from Bioground
(Chongqing). HBsAg, HBcAg, HBeAg, enzyme-labeled anti-
body diluent, GAbs, and MAbs were purchased from Bai
Aotong (Luoyang). 2-(4-Morpholino)ethanesulfonic acid
(MES), catalase, and N-(3-dimethylaminopropyl)-N′-ethyl-
carbodiimide hydrochloride (EDC) were purchased from
Sigma. NH2−PEG−COOH was purchased from Peng Sheng
Biological (Shanghai). The PSs−COOH (300 nm) was made
in the laboratory. Chloroauric acid (HAuCl4) was purchased
from Macklin. BSA was purchased from BioFroxx. The
remaining drugs were bought from Chron Chemicals. All the
experiments used ultrapure water (18.2 MΩ cm).
4.2. Preparation of PSs@CAT@PEG@GAbs. First, the
CAT must be purified because the purchased CAT solution is
a suspension in which the CAT is not sufficiently dissolved. A
part of the CAT stock solution was centrifuged, the
supernatant was collected, and the precipitate was dispersed
in 0.01 M PBS buffer (pH = 7.2) and centrifuged until the
supernatant was colorless and transparent. After combining all
the supernatants, an ultrafiltration tube was used to
concentrate the samples, and the samples were washed with
0.01 M PBS buffer (pH = 7.2). Eventually, the remaining liquid
in the ultrafiltration tube was adjusted to a constant volume
and concentration, and the resulting liquid was used for the
CAT experiment and stored at 4 °C.
The preparation of carboxylated PSs was described by Xie et
al.25 The preparation of PSs@CAT@PEG@GAbs was
described by Hou et al., and some improvements were
made.26 PSs (1 mg), 0.7 mg of CAT, and 10 mL of 0.01 M
PBS buffer were added to a round-bottom flask. After stirring
at 25 °C for 1 h, 300 μL of the EDC solution was added and
stirring was continued for 4 h. The mixture was washed once
with 1× PBS buffer to obtain the PSs@CAT complex and then
stored at 4 °C. The methods for the preparation of PSs@
CAT@PEG and PSs@CAT@PEG@GAbs were the same as
that for the PSs@CAT complex.
4.3. Detection of HBsAg. First, 100 μL of 2 μg/mL MAbs
solution prepared with CB buffer was added to each well of the
microplate and washed with PBST buffer after reacting at 37
°C for 2 h. Then, the plate was blocked with 1× PBS solution
(containing 20 mg/mL BSA) for 1 h and washed with PBST
buffer. It was then stored at 4 °C.
In a microplate coated with MAbs, 100 μL of HBsAg
solution diluted with 2 mg/mL BSA solution (containing
0.05% Tween 20, prepared with 1× PBS buffer) was added to
different concentrations in the sequence and then washed with
PBST buffer after reacting at 37 °C for 75 min. Then, 20 μL of
PSs@CAT@PEG@GAbs and 80 μL of enzyme-labeled
antibody diluent were added. After reacting at 37 °C for 45
min, the cells were washed with PBST buffer 3 times, 1× PBS
buffer twice, and water once. Subsequently, a certain amount of
H2O2 diluted with 1 mMMES buffer (the pH of the buffer was
adjusted to 6.50 with NaOH) was added to each well. After
reacting at 37 °C for 30 min, the chloroauric acid solution was
added to react for 30 min at 37 °C. A microplate reader was
used to detect the absorbance of the solution at 540 nm.
According to the difference in the absorbance between the
control group and the experimental group, we established a
linear relationship between the difference in the absorbance
and the corresponding HBsAg concentration.
The specific steps of detection were the same as the steps for
detecting HBsAg in PBS buffer.
4.4. HBsAg Detection in Human Serum. To verify the
feasibility of this method for testing actual samples, HBsAg was
added to a normal human serum (from a volunteer) diluted
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